News from Lineberger Archives - Page 2 of 86

A woman in a doctor's office having a fertility preservation consultation with a physician.

Learn how cancer treatments affect fertility and the steps you can take for future family planning if you’re a young person diagnosed with cancer.

Five pediatric nurses wearing light blue scrubs in front of a playful painted mural in the clinic's playroom.

At the Reelin’ for Research Pediatric Hematology-Oncology Clinic, a key addition made to the outpatient care team has improved patient care, trust and clinic efficiency.

John West, PhD, is the director of cellular therapy production at the UNC Lineberger Advanced Cellular Therapeutics Facility, which produces CAR-T therapies to treat cancer.

Human cells with acute myelocytic leukemia (AML) in the pericardial fluid, shown with an esterase stain at 400x magnification.

UNC Lineberger researchers have demonstrated a faster, more cost-effective approach to analyzing the genetic makeup of pediatric acute leukemia. Determining a cancer’s genomic classification is critical to developing a more effective treatment plan tailored to a patient’s tumor.

Scientific illustration of a macrophage devouring a cancer cell.

UNC Lineberger researchers report their findings that an experimental immunotherapy using chimeric antigen receptor macrophages (CAR-M) is safe and helps activate the body’s immune system against certain solid cancers.

A smiling physician sitting next to a patient, holding their hand in a comforting and supportive gesture.

You don’t just want a good cancer treatment center—you want a cancer center that’s a good match for you. Ask yourself these six questions when evaluating your options for care.

The rise of colorectal cancer cases in people under 45 has steadily increased, prompting concern among oncologists and researchers. Ashwin Somasundaram, MD, talks about colorectal cancer and this concerning trend.

Histopathologic image illustrating well differentiated squamous cell carcinoma in the excisional biopsy specimen.

Robert Ferris, MD, PhD, and colleagues report in Cancer Cell that head and neck squamous cell carcinomas responded better to a combination of two immunotherapies than to one immunotherapy drug.

A multiple myeloma physician talking with a nurse in the clinic.

March is Multiple Myeloma Awareness Month, an opportunity to shed light on a disease that accounts for approximately 10% of all blood cancers. Treatment options for multiple myeloma have expanded in recent years, leading to better patient outcomes and longer survival rates.

A group of people with their hands stacked in a team-like gesture.

MaTRIC is an initiative providing research project management services and resources to enhance population science research at UNC Lineberger.

Category: News from Lineberger

Preserving fertility before cancer treatment

Pediatric care partners help improve the outpatient experience

A few minutes with John West, PhD

Adaptive whole-genome sequencing could transform childhood leukemia diagnosis

Experimental CAR-M immunotherapy shows promise in solid tumors

Six questions to ask when choosing a cancer treatment center

Gastrointestinal oncologist discusses increase in younger patients with colorectal cancer

Combination immunotherapy before surgery may increase survival in people with head and neck cancer

Improved multiple myeloma therapies help patients live longer, better lives

MaTRIC streamlines project management, resources to boost research productivity